Should I buy or sell Syncona stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Syncona in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SYNC shares. View SYNC analyst ratings or view top-rated stocks .

What is Syncona's stock price target for 2024?

1 analysts have issued 1-year price objectives for Syncona's shares. Their SYNC share price targets range from GBX 230 to GBX 230. On average, they expect the company's share price to reach GBX 230 in the next twelve months. This suggests a possible upside of 83.7% from the stock's current price. View analysts price targets for SYNC or view top-rated stocks among Wall Street analysts .

How have SYNC shares performed in 2023?

Syncona's stock was trading at GBX 181 at the beginning of the year. Since then, SYNC shares have decreased by 30.8% and is now trading at GBX 125.21. View the best growth stocks for 2023 here .

Is Syncona a good dividend stock?

Syncona (LON:SYNC) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.04%. Read our dividend analysis for SYNC .

What other stocks do shareholders of Syncona own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syncona investors own include Rexahn Pharmaceuticals (REXN) , Barrick Gold (ABX) , Agnico Eagle Mines (AEM) , Franco-Nevada (FNV) , Goldex Resources (GDX) , VanEck Gold Miners ETF (GDX) , Goldcorp (GG) , Barrick Gold (GOLD) and Northern Dynasty Minerals (NAK) .

How do I buy shares of Syncona?

Shares of SYNC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

Syncona Share Price, News & Analysis (LON:SYNC)

GBX 124.40

-0.80 (-0.64%)

(As of 04:35 PM ET)

Compare

Today's Range: 124.20
▼
126
50-Day Range: 106.20
▼
135
52-Week Range: 105
▼
197

Volume: 375,965 shs
Average Volume: 608,443 shs
Market Capitalization: £832.57 million

P/E Ratio: N/A
Dividend Yield: 1.61%
Price Target: GBX 230

Stock Analysis Analyst Forecasts Chart Competitors Headlines Insider Trades

Syncona MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 83.7% Upside
GBX 230 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.57
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Syncona has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 230, Syncona has a forecasted upside of 83.7% from its current price of GBX 125.21.
Amount of Analyst Coverage
Syncona has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for SYNC.

0.8

Dividend Strength

Dividend Yield
Syncona pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Syncona does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SYNC.

2.5

News and Social Media Coverage

News Sentiment
Syncona has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Financial Services companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Syncona this week, compared to 0 articles on an average week.
Search Interest
3 people have searched for SYNC on MarketBeat in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Syncona insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.20% of the stock of Syncona is held by insiders.
Percentage Held by Institutions
70.76% of the stock of Syncona is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Syncona is -1,565.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Syncona is -1,565.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Syncona has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Syncona Stock (LON:SYNC)

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.

SYNC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SYNC Stock News Headlines

December 5, 2023 | americanbankingnews.com

Syncona's (SYNC) "Buy" Rating Reaffirmed at Numis Securities

December 4, 2023 | markets.businessinsider.com

Syncona Portfolio Firm Beacon's AGTC-501 Trial Shows Positive Data In X-Linked Retinitis Pigmentosa

December 7, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 23, 2023 | msn.com

BRIEF-Syncona Ltd To Acquire Freeline Therapeutics

November 22, 2023 | marketwatch.com

Freeline Therapeutics Shares Rise on Takeover by Syncona

November 22, 2023 | msn.com

Gene Therapy Player Freeline Therapeutics Goes Private In $28M Deal

November 22, 2023 | marketwatch.com

Freeline Therapeutics Agrees to Buyout by Syncona

November 22, 2023 | markets.businessinsider.com

Freeline Therapeutics To Be Bought By Syncona For $28.3 Mln In Cash; Freeline Stock Up

December 7, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

November 22, 2023 | msn.com

Freeline Therapeutics to be acquired by Syncona for $28.3M in cash

November 22, 2023 | finance.yahoo.com

Syncona to Acquire Freeline Therapeutics

November 16, 2023 | lse.co.uk

Syncona reports declining asset value as investment head steps down

October 18, 2023 | markets.businessinsider.com

Syncona Proposes To Acquire Freeline Therapeutics

October 18, 2023 | msn.com

Freeline gains on non-binding buyout offer from Syncona

October 18, 2023 | marketwatch.com

Syncona Seeks to Buy Remaining Shares of Freeline Therapeutics

October 16, 2023 | finance.yahoo.com

SwanBio Evolves Leadership Team with Appointment of Executive Chair and Chief Operating Officer

October 16, 2023 | marketwatch.com

Syncona Portfolio Company to Present Updated Data on Cancer Study

October 4, 2023 | finanznachrichten.de

SwanBio Therapeutics: SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathy

October 4, 2023 | finance.yahoo.com

SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathy

September 29, 2023 | marketwatch.com

Syncona to Buy Back Up to GBP40 Mln in Shares

September 27, 2023 | tmcnet.com

Forcefield Therapeutics appoints John Tsai MD as Chief Executive Officer

September 12, 2023 | msn.com

Novartis recalls Sandimmune oral solution due to crystal formation

September 11, 2023 | uk.investing.com

FTSE 250 movers: Vistry surges, Syncona sinks on write-off

September 11, 2023 | thetimes.co.uk

Syncona downcast as eye treatment is discontinued

September 11, 2023 | uk.finance.yahoo.com

UK's Syncona writes off 54.5 million stg after Novartis ends Gyroscope's therapy

September 11, 2023 | lse.co.uk

Syncona suffers negative valuation hit as Novartis discontinues GT005

September 11, 2023 | reuters.com

UPDATE 1-UK Stocks-Factors to watch on Sept 11

See More Headlines

Receive SYNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syncona and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Asset Management
Sub-Industry: N/A
Sector: Financial Services
Current Symbol: LON:SYNC
Previous Symbol: LON:BACT
CUSIP: N/A
CIK: N/A
Web: www.bacitltd.com
Phone: 17168531362
Fax: N/A
Employees: 1,208
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 230
High Stock Price Target: GBX 230
Low Stock Price Target: GBX 230
Potential Upside/Downside: +83.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX (0.08)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-56,020,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -4.37%
Return on Assets: -2.47%

Debt

Debt-to-Equity Ratio: 64.05
Current Ratio: 0.74
Quick Ratio: 0.53

Sales & Book Value

Annual Sales: £-39,790,000.00
Price / Sales: -21.06
Cash Flow: GBX 106.60 per share
Price / Cash Flow: 1.17
Book Value: GBX 187 per share
Price / Book: 0.67

Miscellaneous

Outstanding Shares: 669,270,000
Free Float: N/A
Market Cap: £837.93 million
Optionable: Not Optionable
Beta: 0.31

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Thomas Henderson (Age 57)
Co-Founder & Non-Exec. Director
Dr. Martin Patrick Murphy Ph.D. (Age 55)
Chief Exec. Officer
Mr. John McDonald (Age 58)
Co-Founder
Mr. Rolf Kristian Berndtson Soderstrom ACA (Age 57)
BA, Chief Financial Officer
Mr. Ben Woolven
Bus. Strategy and Operations Partner
Dr. Christopher J. Hollowood Ph.D. (Age 48)
CIO & Managing Partner of Syncona Investment Management Ltd.
Ms. Annabel Clark
Head of Investor Relations and Communications
Mr. Andrew Cossar
Gen. Counsel
Ms. Fenella Dernie
Exec. Officer
Mr. Edward Eliot Hodgkin DPhil (Age 60)
Managing Partner

Key Competitors

View All Competitors

SYNC Stock Analysis - Frequently Asked Questions

Should I buy or sell Syncona stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Syncona in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SYNC shares.
View SYNC analyst ratings or view top-rated stocks.
What is Syncona's stock price target for 2024?: 1 analysts have issued 1-year price objectives for Syncona's shares. Their SYNC share price targets range from GBX 230 to GBX 230. On average, they expect the company's share price to reach GBX 230 in the next twelve months. This suggests a possible upside of 83.7% from the stock's current price.
View analysts price targets for SYNC or view top-rated stocks among Wall Street analysts.
How have SYNC shares performed in 2023?: Syncona's stock was trading at GBX 181 at the beginning of the year. Since then, SYNC shares have decreased by 30.8% and is now trading at GBX 125.21.
View the best growth stocks for 2023 here.
Is Syncona a good dividend stock?: Syncona (LON:SYNC) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.04%.
Read our dividend analysis for SYNC.

What other stocks do shareholders of Syncona own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Syncona investors own include Rexahn Pharmaceuticals (REXN), Barrick Gold (ABX), Agnico Eagle Mines (AEM), Franco-Nevada (FNV), Goldex Resources (GDX), VanEck Gold Miners ETF (GDX), Goldcorp (GG), Barrick Gold (GOLD) and Northern Dynasty Minerals (NAK).
How do I buy shares of Syncona?: Shares of SYNC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SYNC) was last updated on 12/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Syncona Share Price, News & Analysis (LON:SYNC)

Syncona MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Syncona Stock (LON:SYNC)

SYNC Stock Price History

SYNC Stock News Headlines

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SYNC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™